학술논문
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma
Document Type
Article
Author
Source
In European Journal of Cancer July 2024 205
Subject
Language
ISSN
0959-8049